Healthcare >> CEO Interviews >> September 14, 2001
NANCY T. CHANG is President and Chief Executive Officer of Tanox, Inc.
Dr. Chang draws on 22 years of biotechnology experience to guide the
company's strategic vision. Previously, Dr. Chang served as Chairman of
the Board of Directors since she co-founded the company in 1986 to March
2004. She has been CEO since June 1990. Tanox was created to address
significant unmet medical needs in the areas of asthma, allergy,
inflammation and diseases affecting the human immune system. Before
launching Tanox, Dr. Chang served as Associate Professor at Baylor
College of Medicine in the division of Molecular Virology and as
Director of Research, Molecular Biology Group, for Centocor, Inc., a
biopharmaceutical company. Dr. Chang has received numerous academic,
national and international awards for her business acumen and
contributions to the biopharmaceutical industry. She was inducted into
the Texas Science Hall of Fame in 2001 for exemplary achievement in
science and is the recipient of several awards, such as the Association
of Women in Computing: Top 20 Houston Women in Technology and Houston
Entrepreneur of Year. As an active member in the biopharmaceutical
industry, Dr. Chang has published more than 35 papers on topics ranging
from monoclonal antibodies to HIV and holds seven patents. She is a
current Board member of the Houston Technology Center, BioHouston and
the Greater Houston Partnership. She received her Doctorate in
Biological Chemistry from Harvard University. Profile
MICHAEL A. KELLY joined Tanox, Inc., as Chief Financial Officer in
October 2000. Prior to joining Tanox, Mr. Kelly held the position of
Corporate Controller of Biogen, Inc., where he was responsible for
worldwide financial strategy, planning and organizational development.
Before joining Biogen in 1998, he held numerous increasingly responsible
senior management positions with Monsanto Life Sciences Company from
1991 to 1998, including Vice President, Finance and Information
Technology. Mr. Kelly received his Bachelor of Science degree in
Business Administration from Florida A&M University. Profile
Dr. Chang: Tanox was formed in 1986 to develop innovative therapeutics
for treating diseases that affect the human immune
